{"transactions":[{"id":764703,"issuer":{"id":1639,"kind":"organization","name":"Chubb Ltd","symbol":"CB"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-05-26T20:20:17.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":1135,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the \"Plan\"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the \"Plan\"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date."}],"balance_after":21626,"source":{"system":"sec-edgar","filing":"0001193125-26-239385","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/896159/000119312526239385/ownership.xml","form_type":"4"}},{"id":797082,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2026-05-01T00:07:35.000Z","date":"2026-04-28","kind":"grant","planned":false,"acquired":true,"shares":68693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":68693,"derivative":{"exercise_price":9.61,"expiration_date":"2036-04-28","underlying":"Common Shares","underlying_shares":68693},"source":{"system":"sec-edgar","filing":"0001232505-26-000003","document":"wk-form4_1777594053.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000123250526000003/wk-form4_1777594053.xml","form_type":"4"}},{"id":1146294,"issuer":{"id":1639,"kind":"organization","name":"Chubb Ltd","symbol":"CB"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-05-16T22:51:01.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":1284,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the \"Plan\"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the \"Plan\"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date."}],"balance_after":20491,"source":{"system":"sec-edgar","filing":"0001213900-25-045003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/896159/000121390025045003/ownership.xml","form_type":"4"}},{"id":1156312,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-05-07T21:11:58.000Z","date":"2025-05-05","kind":"grant","planned":false,"acquired":true,"shares":31716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 5, 2026 or (b) the date of the 2026 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":31716,"derivative":{"exercise_price":22.62,"expiration_date":"2035-05-05","underlying":"Common Shares","underlying_shares":31716},"source":{"system":"sec-edgar","filing":"0001935979-25-000041","document":"wk-form4_1746652311.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000041/wk-form4_1746652311.xml","form_type":"4"}},{"id":1512569,"issuer":{"id":1639,"kind":"organization","name":"Chubb Ltd","symbol":"CB"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-05-17T16:53:08.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":1227,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan, which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan, which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date."}],"balance_after":19207,"source":{"system":"sec-edgar","filing":"0001213900-24-044606","document":"marketforms-65942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/896159/000121390024044606/marketforms-65942.xml","form_type":"4"}},{"id":1530693,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-02T23:33:21.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":16592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 30, 2025 or (b) the date of the 2025 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":16592,"derivative":{"exercise_price":38.8,"expiration_date":"2034-04-30","underlying":"Common Shares","underlying_shares":16592},"source":{"system":"sec-edgar","filing":"0001562180-24-003752","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024003752/primarydocument.xml","form_type":"4"}},{"id":1885772,"issuer":{"id":1639,"kind":"organization","name":"Chubb Ltd","symbol":"CB"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-05-19T14:00:55.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":1634,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan, which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan, which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date."}],"balance_after":17980,"source":{"system":"sec-edgar","filing":"0001209191-23-030878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/896159/000120919123030878/doc4.xml","form_type":"4"}},{"id":1904635,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-04T21:51:09.000Z","date":"2023-05-02","kind":"grant","planned":false,"acquired":true,"shares":52906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 2, 2024 or (b) the date of the 2024  Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":52906,"derivative":{"exercise_price":13.2,"expiration_date":"2033-05-02","underlying":"Common Shares","underlying_shares":52906},"source":{"system":"sec-edgar","filing":"0001562180-23-003940","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218023003940/primarydocument.xml","form_type":"4"}},{"id":2138477,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-12T22:31:18.000Z","date":"2022-10-03","kind":"tax_withholding","acquired":false,"shares":12959,"price":7.5,"value":97192.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer in connection with share settlement to cover the cost of the stock options."},{"field":"shares","element":"transactionShares","label":"F2","text":"This amendment is being filed to correct the amount of shares beneficially owned reported in the Form 4 filed on October 5, 2022 (the \"Original Form 4\"). The Original Form 4 inadvertently incorrectly reported that 3,263 shares were withheld by the Issuer in connection with the share settlement to cover the cost of the stock options; however, as reflected in this amendment, 9,790 shares were withheld by the Issuer in connect with the share settlement to cover the cost of the stock options. There were no other changes made to the information in the Original Form 4."}],"balance_after":12959,"source":{"system":"sec-edgar","filing":"0001562180-22-007175","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007175/primarydocument.xml","form_type":"4/A","original_submission_date":"2022-10-05"}},{"id":2142501,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:37:13.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option vest in four equal installments on October 3, 2022, 2023, 2024, and 2025, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":125000,"derivative":{"exercise_price":7,"expiration_date":"2032-10-04","underlying":"Common Shares","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001562180-22-007077","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007077/primarydocument.xml","form_type":"4"}},{"id":2142500,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:37:13.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":9474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":3.39,"expiration_date":"2030-06-09","underlying":"Common Shares","underlying_shares":9474},"source":{"system":"sec-edgar","filing":"0001562180-22-007077","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007077/primarydocument.xml","form_type":"4"}},{"id":2142499,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:37:13.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":5998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":3.56,"expiration_date":"2031-05-05","underlying":"Common Shares","underlying_shares":5998},"source":{"system":"sec-edgar","filing":"0001562180-22-007077","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007077/primarydocument.xml","form_type":"4"}},{"id":2142498,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:37:13.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":4119,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":4.84,"expiration_date":"2032-04-28","underlying":"Common Shares","underlying_shares":4119},"source":{"system":"sec-edgar","filing":"0001562180-22-007077","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007077/primarydocument.xml","form_type":"4"}},{"id":2142497,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:37:13.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":9474,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":9474,"derivative":{"exercise_price":3.39,"expiration_date":"2030-06-09","underlying":"Common Shares","underlying_shares":9474},"source":{"system":"sec-edgar","filing":"0001562180-22-007077","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007077/primarydocument.xml","form_type":"4"}},{"id":2142496,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:37:13.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":5998,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":5998,"derivative":{"exercise_price":3.56,"expiration_date":"2031-05-05","underlying":"Common Shares","underlying_shares":5998},"source":{"system":"sec-edgar","filing":"0001562180-22-007077","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007077/primarydocument.xml","form_type":"4"}},{"id":2142495,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:37:13.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":4119,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":4119,"derivative":{"exercise_price":4.84,"expiration_date":"2032-04-28","underlying":"Common Shares","underlying_shares":4119},"source":{"system":"sec-edgar","filing":"0001562180-22-007077","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007077/primarydocument.xml","form_type":"4"}},{"id":2142494,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-05T21:37:13.000Z","date":"2022-10-03","kind":"tax_withholding","acquired":false,"shares":3263,"price":7.5,"value":24472.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer in connection with share settlement to cover the cost of the stock options."}],"balance_after":19486,"source":{"system":"sec-edgar","filing":"0001562180-22-007077","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007077/primarydocument.xml","form_type":"4"}},{"id":2142493,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-05T21:37:13.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":9474,"price":3.39,"value":32116.86,"ownership":{"direct":true},"balance_after":22749,"source":{"system":"sec-edgar","filing":"0001562180-22-007077","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007077/primarydocument.xml","form_type":"4"}},{"id":2142492,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-05T21:37:13.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":5998,"price":3.56,"value":21352.88,"ownership":{"direct":true},"balance_after":13275,"source":{"system":"sec-edgar","filing":"0001562180-22-007077","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007077/primarydocument.xml","form_type":"4"}},{"id":2142491,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-05T21:37:13.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":4119,"price":4.84,"value":19935.96,"ownership":{"direct":true},"balance_after":7277,"source":{"system":"sec-edgar","filing":"0001562180-22-007077","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007077/primarydocument.xml","form_type":"4"}},{"id":2142490,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-05T21:37:13.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":1708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Effective as of the Distribution, each outstanding restricted share unit of RemainCo was adjusted so that such restricted share unit became a restricted share unit in respect of Common Shares (each, an \"Issuer RSU\") and a restricted share unit in respect of RemainCo common shares. At the effective time of the merger of a wholly owned subsidiary of Pfizer (\"Merger Sub\") with and into RemainCo pursuant to the Agreement and Plan of Merger, dated as of May 9, 2022, by and among RemainCo, Pfizer and Merger Sub, the Issuer RSUs accelerated and vested in full and were subsequently settled in Common Shares. As a result, the Reporting Person acquired restricted share units in respect of Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":3158,"source":{"system":"sec-edgar","filing":"0001562180-22-007077","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007077/primarydocument.xml","form_type":"4"}},{"id":2142489,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-05T21:37:13.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":1450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares of the Issuer (\"Common Shares\") acquired by the Reporting Person in a pro rata distribution by Biohaven Pharmaceutical Holding Company Ltd.. (\"RemainCo\") to holders of its common shares (the \"Distribution\") pursuant to the Separation and Distribution Agreement (the \"Separation Agreement\"), dated as of May 9, 2022, by and among RemainCo, the Issuer, and Pfizer Inc. (\"Pfizer\")."}],"balance_after":1450,"source":{"system":"sec-edgar","filing":"0001562180-22-007077","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007077/primarydocument.xml","form_type":"4"}},{"id":2147418,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-03T20:25:10.000Z","date":"2022-10-03","kind":"disposition_to_issuer","acquired":false,"shares":18948,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"shares","element":"transactionShares","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":66.88,"expiration_date":"2030-06-09","underlying":"Common Shares","underlying_shares":18948},"source":{"system":"sec-edgar","filing":"0001562180-22-006961","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218022006961/primarydocument.xml","form_type":"4"}},{"id":2147417,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-03T20:25:10.000Z","date":"2022-10-03","kind":"disposition_to_issuer","acquired":false,"shares":11996,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"shares","element":"transactionShares","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":70.17,"expiration_date":"2031-05-05","underlying":"Common Shares","underlying_shares":11996},"source":{"system":"sec-edgar","filing":"0001562180-22-006961","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218022006961/primarydocument.xml","form_type":"4"}},{"id":2147416,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-03T20:25:10.000Z","date":"2022-10-03","kind":"disposition_to_issuer","acquired":false,"shares":8239,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"shares","element":"transactionShares","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":95.33,"expiration_date":"2032-04-28","underlying":"Common Shares","underlying_shares":8239},"source":{"system":"sec-edgar","filing":"0001562180-22-006961","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218022006961/primarydocument.xml","form_type":"4"}},{"id":2147415,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Unit Award","published_at":"2022-10-03T20:25:10.000Z","date":"2022-10-03","kind":"disposition_to_issuer","acquired":false,"shares":3417,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Under the Agreement and Plan of Merger, dated as of May 9, 2022 (the \"Merger Agreement\"), by and among the Issuer, Pfizer Inc. (\"Pfizer\") and a wholly owned subsidiary of Pfizer (\"Merger Sub\"), following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on October 3, 2022 Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"In connection with the distribution (\"Distribution\") by the Issuer to holders of its common shares of all the outstanding common shares of Biohaven Ltd. (\"SpinCo\"), each outstanding restricted share unit of the Issuer was adjusted such that such restricted share unit became a restricted share unit in respect of common shares of SpinCo and a restricted share unit in respect of Common Shares (each such restricted share unit, a \"Post-Spin Issuer RSU\"). At the effective time of the Merger, each outstanding Post-Spin Issuer RSU was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the number of Common Shares subject to such Post-Spin Issuer RSU, with any performance conditions applicable to such Post-Spin Issuer RSU deemed achieved at 100%, and (ii) the Merger Consideration, less any withholding taxes."},{"field":"shares","element":"transactionShares","label":"F3","text":"In connection with the distribution (\"Distribution\") by the Issuer to holders of its common shares of all the outstanding common shares of Biohaven Ltd. (\"SpinCo\"), each outstanding restricted share unit of the Issuer was adjusted such that such restricted share unit became a restricted share unit in respect of common shares of SpinCo and a restricted share unit in respect of Common Shares (each such restricted share unit, a \"Post-Spin Issuer RSU\"). At the effective time of the Merger, each outstanding Post-Spin Issuer RSU was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the number of Common Shares subject to such Post-Spin Issuer RSU, with any performance conditions applicable to such Post-Spin Issuer RSU deemed achieved at 100%, and (ii) the Merger Consideration, less any withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the distribution (\"Distribution\") by the Issuer to holders of its common shares of all the outstanding common shares of Biohaven Ltd. (\"SpinCo\"), each outstanding restricted share unit of the Issuer was adjusted such that such restricted share unit became a restricted share unit in respect of common shares of SpinCo and a restricted share unit in respect of Common Shares (each such restricted share unit, a \"Post-Spin Issuer RSU\"). At the effective time of the Merger, each outstanding Post-Spin Issuer RSU was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the number of Common Shares subject to such Post-Spin Issuer RSU, with any performance conditions applicable to such Post-Spin Issuer RSU deemed achieved at 100%, and (ii) the Merger Consideration, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"In connection with the distribution (\"Distribution\") by the Issuer to holders of its common shares of all the outstanding common shares of Biohaven Ltd. (\"SpinCo\"), each outstanding restricted share unit of the Issuer was adjusted such that such restricted share unit became a restricted share unit in respect of common shares of SpinCo and a restricted share unit in respect of Common Shares (each such restricted share unit, a \"Post-Spin Issuer RSU\"). At the effective time of the Merger, each outstanding Post-Spin Issuer RSU was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the number of Common Shares subject to such Post-Spin Issuer RSU, with any performance conditions applicable to such Post-Spin Issuer RSU deemed achieved at 100%, and (ii) the Merger Consideration, less any withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"In connection with the distribution (\"Distribution\") by the Issuer to holders of its common shares of all the outstanding common shares of Biohaven Ltd. (\"SpinCo\"), each outstanding restricted share unit of the Issuer was adjusted such that such restricted share unit became a restricted share unit in respect of common shares of SpinCo and a restricted share unit in respect of Common Shares (each such restricted share unit, a \"Post-Spin Issuer RSU\"). At the effective time of the Merger, each outstanding Post-Spin Issuer RSU was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the number of Common Shares subject to such Post-Spin Issuer RSU, with any performance conditions applicable to such Post-Spin Issuer RSU deemed achieved at 100%, and (ii) the Merger Consideration, less any withholding taxes."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":3417},"source":{"system":"sec-edgar","filing":"0001562180-22-006961","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218022006961/primarydocument.xml","form_type":"4"}},{"id":2147414,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-03T20:25:10.000Z","date":"2022-10-03","kind":"disposition_to_issuer","acquired":false,"shares":2900,"price":148.5,"value":430650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under the Agreement and Plan of Merger, dated as of May 9, 2022 (the \"Merger Agreement\"), by and among the Issuer, Pfizer Inc. (\"Pfizer\") and a wholly owned subsidiary of Pfizer (\"Merger Sub\"), following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on October 3, 2022 Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In the Merger, each common share of the Issuer (each, a \"Common Share\") outstanding immediately prior to the effective time of the Merger (other than certain excluded shares pursuant to the terms of the Merger Agreement), was converted into the right to receive the merger consideration in cash of $148.50, without interest, less any withholding taxes (the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-22-006961","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218022006961/primarydocument.xml","form_type":"4"}},{"id":2260785,"issuer":{"id":1639,"kind":"organization","name":"Chubb Ltd","symbol":"CB"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-05-23T16:55:37.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":1594,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the \"Plan\"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the \"Plan\"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date."}],"balance_after":16346,"source":{"system":"sec-edgar","filing":"0001209191-22-031281","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/896159/000120919122031281/doc4.xml","form_type":"4"}},{"id":2287934,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-29T21:00:19.000Z","date":"2022-04-28","kind":"grant","acquired":true,"shares":8239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2023 or (b) the date of the 2023 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":8239,"derivative":{"exercise_price":97.74,"expiration_date":"2032-04-27","underlying":"Common Shares","underlying_shares":8239},"source":{"system":"sec-edgar","filing":"0001562180-22-003585","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218022003585/primarydocument.xml","form_type":"4"}},{"id":2461084,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Unit Award","published_at":"2021-12-22T21:52:10.000Z","date":"2021-12-20","kind":"grant","acquired":true,"shares":3417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents the contingent right to receive one common share of the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted share unit represents the contingent right to receive one common share of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person was granted 3,417 restricted share units on December 20, 2021, which vested immediately upon grant. These restricted share units will settle on a deferred basis upon the reporting person's retirement from the Board of Directors of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":3417,"derivative":{"underlying":"Common Shares","underlying_shares":3417},"source":{"system":"sec-edgar","filing":"0001562180-21-007870","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218021007870/primarydocument.xml","form_type":"4"}},{"id":2699717,"issuer":{"id":1639,"kind":"organization","name":"Chubb Ltd","symbol":"CB"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-05-24T18:32:36.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":1836,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the \"Plan\"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the \"Plan\"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date."}],"balance_after":14752,"source":{"system":"sec-edgar","filing":"0001209191-21-035243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/896159/000120919121035243/doc4.xml","form_type":"4"}},{"id":2723211,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-07T16:33:57.000Z","date":"2021-05-05","kind":"grant","acquired":true,"shares":11996,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 5, 2022 or (b) the date of the 2022 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":11996,"derivative":{"exercise_price":71.94,"expiration_date":"2031-05-04","underlying":"Common Shares","underlying_shares":11996},"source":{"system":"sec-edgar","filing":"0001562180-21-003335","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218021003335/primarydocument.xml","form_type":"4"}},{"id":2770643,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2021-03-26T16:14:26.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":18948,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 12, 2020, the reporting person filed a Form 4 in respect of 36,000 options granted pursuant to the issuer's non-employee director compensation policy.  The issuer subsequently determined that 17,052 of the options comprising such award were null and void upon grant as a result of the $1,000,000 annual limit for non-employee director compensation under its 2017 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option grant was made pursuant to the issuer's non-employee director compensation policy. The common shares underlying this option vest in three equal installments on June 9, 2021, 2022, and 2023, subject to the reporting person's continuous service with the issuer at each vesting date."}],"balance_after":18948,"derivative":{"exercise_price":68.57,"expiration_date":"2030-06-09","underlying":"Common Shares","underlying_shares":18948},"source":{"system":"sec-edgar","filing":"0001562180-21-002442","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218021002442/primarydocument.xml","form_type":"4/A","original_submission_date":"2020-06-12"}},{"id":3111990,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2020-06-12T17:58:54.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant was made pursuant to the issuer's non-employee director compensation policy. The common shares underlying this option vest in three equal installments on June 9, 2020, 2021, and 2022, subject to the reporting person's continuous service with the issuer at each vesting date."}],"balance_after":36000,"derivative":{"exercise_price":68.57,"expiration_date":"2030-06-09","underlying":"Common Shares","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001562180-20-004470","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218020004470/primarydocument.xml","form_type":"4"}},{"id":3138067,"issuer":{"id":1639,"kind":"organization","name":"Chubb Ltd","symbol":"CB"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-05-22T15:27:32.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":2916,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the \"Plan\"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the \"Plan\"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date."}],"balance_after":12916,"source":{"system":"sec-edgar","filing":"0001209191-20-031598","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/896159/000120919120031598/doc4.xml","form_type":"4"}},{"id":3154174,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2020-05-12T01:58:31.000Z","date":"2020-05-08","kind":"disposition_to_issuer","acquired":false,"shares":4294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the disposition of ordinary shares (\"Allergan Shares\") of Allergan plc (\"Allergan\") as contemplated by the Transaction Agreement dated as of June 25, 2019 among AbbVie Inc. (\"AbbVie\"), Venice Subsidiary, LLC (\"Acquirer Sub\") and Allergan (the \"Transaction Agreement\"), pursuant to which Acquirer Sub acquired Allergan pursuant to a scheme of arrangement under Chapter 1 of Part 9 of the Irish Companies Act of 2014 and the capital reduction under Sections 84 and 85 of the Act (the \"Scheme\").  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each Allergan Share was converted into $120.30 in cash and 0.8660 of a newly issued share of AbbVie common stock, par value $0.01 per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-012762","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232505/000089924320012762/doc4.xml","form_type":"4"}},{"id":3163464,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2020-05-05T00:55:56.000Z","date":"2020-05-01","kind":"tax_withholding","acquired":false,"shares":2064,"price":189.74,"value":391623.36,"ownership":{"direct":true},"balance_after":4294,"source":{"system":"sec-edgar","filing":"0001179110-20-005444","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232505/000117911020005444/edgar.xml","form_type":"4"}},{"id":3542232,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2019-05-02T20:48:02.000Z","date":"2019-05-02","kind":"grant","acquired":true,"shares":2064,"price":145.33,"value":299961.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units shall vest on the earlier of (i) the day before the 2020 Annual General Meeting of Shareholders and (ii) May 1, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":5285,"source":{"system":"sec-edgar","filing":"0001179110-19-005415","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232505/000117911019005415/edgar.xml","form_type":"4"}},{"id":3542231,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2019-05-02T20:48:02.000Z","date":"2019-04-30","kind":"tax_withholding","acquired":false,"shares":205,"price":147,"value":30135.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":3221,"source":{"system":"sec-edgar","filing":"0001179110-19-005415","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232505/000117911019005415/edgar.xml","form_type":"4"}},{"id":3645141,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2019-02-20T16:26:28.000Z","date":"2019-02-18","kind":"grant","acquired":true,"shares":426,"price":139.07,"value":59243.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units shall vest on the earlier of (i) the day before the 2019 Annual General Meeting of Shareholders and (ii) May 2, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":3426,"source":{"system":"sec-edgar","filing":"0001179110-19-002128","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232505/000117911019002128/edgar.xml","form_type":"4"}},{"id":4084027,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Common Stock","published_at":"2018-01-31T16:39:58.000Z","date":"2017-09-07","kind":"gift","acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Gift to a family foundation of which Mr. Hugin is a trustee, but he is not deemed to hold a pecuniary interest in the foundation."}],"balance_after":1015106,"source":{"system":"sec-edgar","filing":"0001209191-18-006228","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919118006228/doc5.xml","form_type":"5"}},{"id":4166027,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right-to-buy)","published_at":"2017-11-13T18:18:25.000Z","date":"2017-11-09","kind":"exercise","acquired":false,"shares":12039,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option vested in one installment beginning on June 22, 2012."}],"balance_after":0,"derivative":{"exercise_price":21.14,"expiration_date":"2022-05-22","underlying":"Common Stock","underlying_shares":12039},"source":{"system":"sec-edgar","filing":"0001179110-17-014063","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911017014063/edgar.xml","form_type":"4"}},{"id":4166026,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right-to-buy)","published_at":"2017-11-13T18:18:25.000Z","date":"2017-11-09","kind":"exercise","acquired":false,"shares":13259,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vested in one installment beginning on June 26, 2011."}],"balance_after":0,"derivative":{"exercise_price":18.18,"expiration_date":"2021-05-26","underlying":"Common Stock","underlying_shares":13259},"source":{"system":"sec-edgar","filing":"0001179110-17-014063","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911017014063/edgar.xml","form_type":"4"}},{"id":4166025,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right-to-buy)","published_at":"2017-11-13T18:18:25.000Z","date":"2017-11-09","kind":"exercise","acquired":false,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vested in twelve equal monthly installments beginning on July 2, 2010."}],"balance_after":0,"derivative":{"exercise_price":8.28,"expiration_date":"2020-06-02","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001179110-17-014063","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911017014063/edgar.xml","form_type":"4"}},{"id":4166024,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right-to-buy)","published_at":"2017-11-13T18:18:25.000Z","date":"2017-11-09","kind":"exercise","acquired":false,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vested in twelve equal monthly installments beginning on June 28, 2009."}],"balance_after":0,"derivative":{"exercise_price":7.51,"expiration_date":"2019-05-28","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001179110-17-014063","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911017014063/edgar.xml","form_type":"4"}},{"id":4166023,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right-to-buy)","published_at":"2017-11-13T18:18:25.000Z","date":"2017-11-09","kind":"exercise","acquired":false,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vested in twelve equal monthly installments beginning on June 29, 2008."}],"balance_after":0,"derivative":{"exercise_price":18.3,"expiration_date":"2018-05-29","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001179110-17-014063","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911017014063/edgar.xml","form_type":"4"}},{"id":4166022,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-13T18:18:25.000Z","date":"2017-11-09","kind":"exercise","acquired":true,"shares":12039,"price":21.14,"value":254504.46,"ownership":{"direct":true},"balance_after":163431,"source":{"system":"sec-edgar","filing":"0001179110-17-014063","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911017014063/edgar.xml","form_type":"4"}},{"id":4166021,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-13T18:18:25.000Z","date":"2017-11-09","kind":"exercise","acquired":true,"shares":13259,"price":18.18,"value":241048.62,"ownership":{"direct":true},"balance_after":151392,"source":{"system":"sec-edgar","filing":"0001179110-17-014063","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911017014063/edgar.xml","form_type":"4"}},{"id":4166020,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-13T18:18:25.000Z","date":"2017-11-09","kind":"exercise","acquired":true,"shares":7500,"price":8.28,"value":62100.0,"ownership":{"direct":true},"balance_after":138133,"source":{"system":"sec-edgar","filing":"0001179110-17-014063","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911017014063/edgar.xml","form_type":"4"}},{"id":4166019,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-13T18:18:25.000Z","date":"2017-11-09","kind":"exercise","acquired":true,"shares":7500,"price":7.51,"value":56325.0,"ownership":{"direct":true},"balance_after":130633,"source":{"system":"sec-edgar","filing":"0001179110-17-014063","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911017014063/edgar.xml","form_type":"4"}},{"id":4166018,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-13T18:18:25.000Z","date":"2017-11-09","kind":"exercise","acquired":true,"shares":7500,"price":18.3,"value":137250.0,"ownership":{"direct":true},"balance_after":123133,"source":{"system":"sec-edgar","filing":"0001179110-17-014063","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911017014063/edgar.xml","form_type":"4"}},{"id":4177911,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Stock Option (right to buy)","published_at":"2017-10-31T21:24:56.000Z","date":"2017-10-30","kind":"grant","acquired":true,"shares":27444,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option is immediately exercisable and will vest in four equal annual installments, commencing on October 30, 2018."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The option was issued pursuant to the Company's 2017 Stock Incentive Plan."}],"balance_after":27444,"derivative":{"exercise_price":100.97,"expiration_date":"2027-10-30","underlying":"Common Stock","underlying_shares":27444},"source":{"system":"sec-edgar","filing":"0001209191-17-058526","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117058526/doc4.xml","form_type":"4"}},{"id":4180333,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Stock Option","published_at":"2017-10-26T16:44:34.000Z","date":"2017-10-26","kind":"exercise","acquired":false,"shares":2020,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued pursuant to the Company's 2017 Stock Incentive  Plan (formerly the 2008 Stock Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":49.48,"expiration_date":"2023-01-28","underlying":"Common Stock","underlying_shares":2020},"source":{"system":"sec-edgar","filing":"0001209191-17-058029","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117058029/doc4.xml","form_type":"4"}},{"id":4180332,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Stock Option","published_at":"2017-10-26T16:44:34.000Z","date":"2017-10-26","kind":"exercise","acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was issued pursuant to the Company's 1998  Employee Stock Option Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":31.21,"expiration_date":"2018-04-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-17-058029","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117058029/doc4.xml","form_type":"4"}},{"id":4180331,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Common Stock","published_at":"2017-10-26T16:44:34.000Z","date":"2017-10-26","kind":"exercise","acquired":true,"shares":2020,"price":49.48,"value":99949.6,"ownership":{"direct":true},"balance_after":1060106,"source":{"system":"sec-edgar","filing":"0001209191-17-058029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117058029/doc4.xml","form_type":"4"}},{"id":4180330,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Common Stock","published_at":"2017-10-26T16:44:34.000Z","date":"2017-10-26","kind":"exercise","acquired":true,"shares":60000,"price":31.21,"value":1872600.0,"ownership":{"direct":true},"balance_after":1058086,"source":{"system":"sec-edgar","filing":"0001209191-17-058029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117058029/doc4.xml","form_type":"4"}},{"id":4247866,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Stock Option (right to buy)","published_at":"2017-08-01T16:52:25.000Z","date":"2017-07-31","kind":"grant","acquired":true,"shares":27443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option is immediately exercisable and will vest in four equal annual installments commencing on July 31, 2018."}],"balance_after":27443,"derivative":{"exercise_price":135.41,"expiration_date":"2027-07-31","underlying":"Common Stock","underlying_shares":27443},"source":{"system":"sec-edgar","filing":"0001209191-17-046930","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117046930/doc4.xml","form_type":"4"}},{"id":4247865,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Restricted Stock Unit","published_at":"2017-08-01T16:52:25.000Z","date":"2017-07-28","kind":"exercise","acquired":false,"shares":44500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All of the restricted stock units granted to the reporting person on July 28, 2014 vested and settled for shares of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All of the restricted stock units granted to the reporting person on July 28, 2014 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the restricted stock units granted to the reporting person on July 28, 2014 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All of the restricted stock units granted to the reporting person on July 28, 2014 vested and settled for shares of the Company's common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":44500},"source":{"system":"sec-edgar","filing":"0001209191-17-046930","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117046930/doc4.xml","form_type":"4"}},{"id":4247864,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Common Stock","published_at":"2017-08-01T16:52:25.000Z","date":"2017-07-28","kind":"tax_withholding","acquired":false,"shares":23073,"price":134.1,"value":3094089.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This amount reflects shares withheld by the Company for the payment of taxes on the vested shares."}],"balance_after":998086,"source":{"system":"sec-edgar","filing":"0001209191-17-046930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117046930/doc4.xml","form_type":"4"}},{"id":4247863,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Common Stock","published_at":"2017-08-01T16:52:25.000Z","date":"2017-07-28","kind":"exercise","acquired":true,"shares":44500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All of the restricted stock units granted to the reporting person on July 28, 2014 vested and settled for shares of the Company's common stock."}],"balance_after":1021159,"source":{"system":"sec-edgar","filing":"0001209191-17-046930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117046930/doc4.xml","form_type":"4"}},{"id":4274045,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Stock Option (right to buy)","published_at":"2017-06-23T16:02:58.000Z","date":"2017-06-22","kind":"exercise","acquired":false,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The option was issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the 2008 Stock Incentive Plan (Amended and Restated as of April 15, 2015))."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":36.36,"expiration_date":"2022-01-30","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0001209191-17-041629","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041629/doc4.xml","form_type":"4"}},{"id":4274044,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Stock Option (right to buy)","published_at":"2017-06-23T16:02:58.000Z","date":"2017-06-22","kind":"exercise","acquired":false,"shares":55970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued pursuant to the Company's 1998 Employee Stock Option Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":24.81,"expiration_date":"2018-01-08","underlying":"Common Stock","underlying_shares":55970},"source":{"system":"sec-edgar","filing":"0001209191-17-041629","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041629/doc4.xml","form_type":"4"}},{"id":4274043,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Stock Option (right to buy)","published_at":"2017-06-23T16:02:58.000Z","date":"2017-06-22","kind":"exercise","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued pursuant to the Company's 1998 Employee Stock Option Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":36.78,"expiration_date":"2017-10-09","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-17-041629","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041629/doc4.xml","form_type":"4"}},{"id":4274042,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Stock Option (right to buy)","published_at":"2017-06-23T16:02:58.000Z","date":"2017-06-22","kind":"exercise","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued pursuant to the Company's 1998 Employee Stock Option Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":29.27,"expiration_date":"2017-07-10","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-17-041629","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041629/doc4.xml","form_type":"4"}},{"id":4274041,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Common Stock","published_at":"2017-06-23T16:02:58.000Z","date":"2017-06-22","kind":"exercise","acquired":true,"shares":2750,"price":36.36,"value":99990.0,"ownership":{"direct":true},"balance_after":976659,"source":{"system":"sec-edgar","filing":"0001209191-17-041629","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041629/doc4.xml","form_type":"4"}},{"id":4274040,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Common Stock","published_at":"2017-06-23T16:02:58.000Z","date":"2017-06-22","kind":"sale","acquired":false,"shares":55970,"price":134.14,"value":7507815.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold by the reporting person in multiple transactions at prices ranging from $134.00 to $135.13, inclusive.  The reporting person undertakes to provide to Celgene Corporation (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":973909,"source":{"system":"sec-edgar","filing":"0001209191-17-041629","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041629/doc4.xml","form_type":"4"}},{"id":4274039,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Common Stock","published_at":"2017-06-23T16:02:58.000Z","date":"2017-06-22","kind":"exercise","acquired":true,"shares":55970,"price":24.81,"value":1388615.7,"ownership":{"direct":true},"balance_after":1029879,"source":{"system":"sec-edgar","filing":"0001209191-17-041629","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041629/doc4.xml","form_type":"4"}},{"id":4274038,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Common Stock","published_at":"2017-06-23T16:02:58.000Z","date":"2017-06-22","kind":"sale","acquired":false,"shares":60000,"price":134.14,"value":8048400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold by the reporting person in multiple transactions at prices ranging from $134.00 to $135.13, inclusive.  The reporting person undertakes to provide to Celgene Corporation (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":973909,"source":{"system":"sec-edgar","filing":"0001209191-17-041629","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041629/doc4.xml","form_type":"4"}},{"id":4274037,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Common Stock","published_at":"2017-06-23T16:02:58.000Z","date":"2017-06-22","kind":"exercise","acquired":true,"shares":60000,"price":33.78,"value":2026800.0,"ownership":{"direct":true},"balance_after":1033909,"source":{"system":"sec-edgar","filing":"0001209191-17-041629","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041629/doc4.xml","form_type":"4"}},{"id":4274036,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Common Stock","published_at":"2017-06-23T16:02:58.000Z","date":"2017-06-22","kind":"sale","acquired":false,"shares":60000,"price":134.14,"value":8048400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold by the reporting person in multiple transactions at prices ranging from $134.00 to $135.13, inclusive.  The reporting person undertakes to provide to Celgene Corporation (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":973909,"source":{"system":"sec-edgar","filing":"0001209191-17-041629","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041629/doc4.xml","form_type":"4"}},{"id":4274035,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Common Stock","published_at":"2017-06-23T16:02:58.000Z","date":"2017-06-22","kind":"exercise","acquired":true,"shares":60000,"price":29.26,"value":1755600.0,"ownership":{"direct":true},"balance_after":1033909,"source":{"system":"sec-edgar","filing":"0001209191-17-041629","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041629/doc4.xml","form_type":"4"}},{"id":4301594,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right-to-buy)","published_at":"2017-05-30T19:52:06.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":8577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in one installment on May 25, 2018 and is made as part of and pursuant to Issuer's director compensation package."}],"balance_after":8577,"derivative":{"exercise_price":39.39,"expiration_date":"2017-05-25","underlying":"Common Stock","underlying_shares":8577},"source":{"system":"sec-edgar","filing":"0001179110-17-008221","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911017008221/edgar.xml","form_type":"4"}},{"id":4301593,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-30T19:52:06.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":3237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This restricted stock award vests on May 25, 2018 and is made as part of and pursuant to Issuer's director compensation package."}],"balance_after":115633,"source":{"system":"sec-edgar","filing":"0001179110-17-008221","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911017008221/edgar.xml","form_type":"4"}},{"id":426424,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2017-05-17T21:31:06.000Z","date":"2017-05-15","kind":"grant","acquired":true,"shares":3540,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3540,"derivative":{"exercise_price":83.28,"exercise_date":"2017-05-15","expiration_date":"2027-05-15","underlying":"Common Stock","underlying_shares":3540},"source":{"system":"sec-edgar","filing":"0000313616-17-000179","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361617000179/edgar.xml","form_type":"4"}},{"id":426423,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-17T21:31:06.000Z","date":"2017-05-15","kind":"grant","acquired":true,"shares":990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated.  Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4.  The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board."}],"balance_after":3576,"source":{"system":"sec-edgar","filing":"0000313616-17-000179","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361617000179/edgar.xml","form_type":"4"}},{"id":4339032,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Restricted Stock Unit","published_at":"2017-05-02T16:19:03.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":13876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The restricted stock units were issued pursuant to the Company's 2008 Stock Incentive Plan (Amended and Restated as of April 15, 2015) and will vest on May 1, 2020.  Vested shares will be delivered to the reporting person on the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were issued pursuant to the Company's 2008 Stock Incentive Plan (Amended and Restated as of April 15, 2015) and will vest on May 1, 2020.  Vested shares will be delivered to the reporting person on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were issued pursuant to the Company's 2008 Stock Incentive Plan (Amended and Restated as of April 15, 2015) and will vest on May 1, 2020.  Vested shares will be delivered to the reporting person on the vesting date."}],"balance_after":13876,"derivative":{"underlying":"Common Stock","underlying_shares":13876},"source":{"system":"sec-edgar","filing":"0001209191-17-029187","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117029187/doc4.xml","form_type":"4"}},{"id":4339031,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Stock Option (right to buy)","published_at":"2017-05-02T16:19:03.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":27443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as Amended and Restated as of April 15, 2015)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option is immediately exercisable and will vest in four equal annual installments commencing on May 1, 2018."}],"balance_after":27443,"derivative":{"exercise_price":124.06,"expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":27443},"source":{"system":"sec-edgar","filing":"0001209191-17-029187","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117029187/doc4.xml","form_type":"4"}},{"id":4354082,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Stock Option","published_at":"2017-04-12T16:24:23.000Z","date":"2017-04-10","kind":"exercise","acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was issued pursuant to the Company's 1998  Employee Stock Option Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":29.02,"expiration_date":"2017-04-10","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-17-026683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117026683/doc4.xml","form_type":"4"}},{"id":4354081,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Common Stock","published_at":"2017-04-12T16:24:23.000Z","date":"2017-04-10","kind":"exercise","acquired":true,"shares":60000,"price":29.02,"value":1741200.0,"ownership":{"direct":true},"balance_after":973909,"source":{"system":"sec-edgar","filing":"0001209191-17-026683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117026683/doc4.xml","form_type":"4"}},{"id":4390977,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right-to-buy)","published_at":"2017-03-10T16:56:13.000Z","date":"2017-03-08","kind":"exercise","acquired":false,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vested in twelve equal monthly installments beginning on June 24, 2007."}],"balance_after":0,"derivative":{"exercise_price":19.6,"expiration_date":"2017-05-24","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001179110-17-004423","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911017004423/edgar.xml","form_type":"4"}},{"id":4390976,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-10T16:56:13.000Z","date":"2017-03-08","kind":"exercise","acquired":true,"shares":7500,"price":19.6,"value":147000.0,"ownership":{"direct":true},"balance_after":112396,"source":{"system":"sec-edgar","filing":"0001179110-17-004423","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911017004423/edgar.xml","form_type":"4"}},{"id":4444111,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Phantom Stock","published_at":"2017-02-16T17:16:03.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":28510,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock represents a right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person was awarded 28,510 shares of common stock pursuant to the 2014-2016 Long Term Incentive Plan under the Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 15, 2015). The reporting person deferred the receipt of such 28,510 shares of common stock and received instead 28,510 shares of phantom stock pursuant to the Celgene Corporation 2005 Deferred Compensation Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The phantom stock becomes payable six months following the reporting person's termination of employment with Celgene Corporation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The phantom stock becomes payable six months following the reporting person's termination of employment with Celgene Corporation."}],"balance_after":28510,"derivative":{"underlying":"Common Stock","underlying_shares":28510},"source":{"system":"sec-edgar","filing":"0001209191-17-011574","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117011574/doc4.xml","form_type":"4"}},{"id":4476106,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Common Stock","published_at":"2017-01-31T16:22:30.000Z","date":"2016-11-09","kind":"gift","acquired":false,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Gift to a family foundation of which Mr. Hugin is a trustee, but he is not deemed to hold a pecuniary interest in the foundation."}],"balance_after":891201,"source":{"system":"sec-edgar","filing":"0001209191-17-006364","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117006364/doc5.xml","form_type":"5"}},{"id":4476105,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-31T16:21:48.000Z","date":"2017-01-30","kind":"grant","acquired":true,"shares":29669,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as Amended and Restated as of April 15, 2015)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option is immediately exercisable and will vest in four equal annual installments commencing on January 30, 2018."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as Amended and Restated as of April 15, 2015)."}],"balance_after":29669,"derivative":{"exercise_price":113.18,"expiration_date":"2027-01-30","underlying":"Common Stock","underlying_shares":29669},"source":{"system":"sec-edgar","filing":"0001209191-17-006363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117006363/doc4.xml","form_type":"4"}},{"id":4495609,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Stock Option","published_at":"2017-01-09T16:11:16.000Z","date":"2017-01-05","kind":"exercise","acquired":false,"shares":22708,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was issued pursuant to the Company's 1998  Employee Stock Option Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":27.425,"expiration_date":"2017-01-09","underlying":"Common Stock","underlying_shares":22708},"source":{"system":"sec-edgar","filing":"0001209191-17-002926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117002926/doc4.xml","form_type":"4"}},{"id":4495608,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Common Stock","published_at":"2017-01-09T16:11:16.000Z","date":"2017-01-05","kind":"exercise","acquired":true,"shares":22708,"price":27.425,"value":622766.9,"ownership":{"direct":true},"balance_after":913909,"source":{"system":"sec-edgar","filing":"0001209191-17-002926","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117002926/doc4.xml","form_type":"4"}},{"id":4559338,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Common Stock","published_at":"2016-11-14T17:47:57.000Z","date":"2016-11-09","kind":"sale","acquired":false,"shares":100000,"price":120,"value":12000000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were sold by the reporting person pursuant to a Rule 10b5-1 plan."}],"balance_after":922201,"source":{"system":"sec-edgar","filing":"0001209191-16-149843","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919116149843/doc4.xml","form_type":"4"}},{"id":4570150,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"see remarks"}}],"security":"Stock Option (right to buy)","published_at":"2016-11-02T16:14:32.000Z","date":"2016-10-31","kind":"grant","acquired":true,"shares":29669,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as Amended and Restated as of April 15, 2015)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option is immediately exercisable and will vest in four equal annual installments commencing on October 31, 2017."}],"balance_after":29669,"derivative":{"exercise_price":102.18,"expiration_date":"2026-10-31","underlying":"Common Stock","underlying_shares":29669},"source":{"system":"sec-edgar","filing":"0001209191-16-147898","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919116147898/doc4.xml","form_type":"4"}},{"id":435967,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-08-04T20:03:30.000Z","date":"2016-07-15","kind":"grant","acquired":true,"shares":970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated.  Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4.  The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amendment is being filed to reflect an additional 1,616 shares in Table 1, Column 5, which were inadvertently omitted from the original filing."}],"balance_after":2586,"source":{"system":"sec-edgar","filing":"0000313616-16-000217","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361616000217/edgar.xml","form_type":"4/A","original_submission_date":"2016-07-19"}},{"id":436696,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2016-07-19T20:49:09.000Z","date":"2016-07-15","kind":"grant","acquired":true,"shares":2930,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2930,"derivative":{"exercise_price":80.92,"exercise_date":"2016-07-15","expiration_date":"2026-07-15","underlying":"Common Stock","underlying_shares":2930},"source":{"system":"sec-edgar","filing":"0000313616-16-000197","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361616000197/edgar.xml","form_type":"4"}},{"id":436695,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-07-19T20:49:09.000Z","date":"2016-07-15","kind":"grant","acquired":true,"shares":970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated.  Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4.  The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board."}],"balance_after":970,"source":{"system":"sec-edgar","filing":"0000313616-16-000197","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361616000197/edgar.xml","form_type":"4"}}]}